Global Nucleic Acid–Based Diagnostic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
LPI (LP Information)' newest research report, the “Nucleic Acid–Based Diagnostic Industry Forecast” looks at past sales and reviews total world Nucleic Acid–Based Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid–Based Diagnostic sales for 2023 through 2029. With Nucleic Acid–Based Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid–Based Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid–Based Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid–Based Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid–Based Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid–Based Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid–Based Diagnostic.
The global Nucleic Acid–Based Diagnostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid–Based Diagnostic players cover Agilent Technologies, Danaher Corporation, Abbott Laboratories, BD, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc. and Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid–Based Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
LPI (LP Information)' newest research report, the “Nucleic Acid–Based Diagnostic Industry Forecast” looks at past sales and reviews total world Nucleic Acid–Based Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid–Based Diagnostic sales for 2023 through 2029. With Nucleic Acid–Based Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid–Based Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid–Based Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid–Based Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid–Based Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid–Based Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid–Based Diagnostic.
The global Nucleic Acid–Based Diagnostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid–Based Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid–Based Diagnostic players cover Agilent Technologies, Danaher Corporation, Abbott Laboratories, BD, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc. and Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid–Based Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Nucleic Acid Molecular Hybridization
- Polymerase Chain Reaction
- Thermostatic Amplification
- Gene Sequencing
- Biochip Technology
- Hospital
- Clinical Laboratory
- Research Institutions
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies
- Danaher Corporation
- Abbott Laboratories
- BD
- Bio-Rad Laboratories
- Roche
- Illumina, Inc
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Qiagen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid–Based Diagnostic Market Size 2018-2029
2.1.2 Nucleic Acid–Based Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid–Based Diagnostic Segment by Type
2.2.1 Nucleic Acid Molecular Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Thermostatic Amplification
2.2.4 Gene Sequencing
2.2.5 Biochip Technology
2.3 Nucleic Acid–Based Diagnostic Market Size by Type
2.3.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Nucleic Acid–Based Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Clinical Laboratory
2.4.3 Research Institutions
2.4.4 Clinic
2.4.5 Other
2.5 Nucleic Acid–Based Diagnostic Market Size by Application
2.5.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
3 NUCLEIC ACID–BASED DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nucleic Acid–Based Diagnostic Market Size Market Share by Players
3.1.1 Global Nucleic Acid–Based Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID–BASED DIAGNOSTIC BY REGIONS
4.1 Nucleic Acid–Based Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
5.3 Americas Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
6.3 APAC Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid–Based Diagnostic by Country (2018-2023)
7.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid–Based Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID–BASED DIAGNOSTIC MARKET FORECAST
10.1 Global Nucleic Acid–Based Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid–Based Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid–Based Diagnostic Forecast
10.1.3 APAC Nucleic Acid–Based Diagnostic Forecast
10.1.4 Europe Nucleic Acid–Based Diagnostic Forecast
10.1.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast
10.2 Americas Nucleic Acid–Based Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid–Based Diagnostic Market Forecast
10.2.2 Canada Nucleic Acid–Based Diagnostic Market Forecast
10.2.3 Mexico Nucleic Acid–Based Diagnostic Market Forecast
10.2.4 Brazil Nucleic Acid–Based Diagnostic Market Forecast
10.3 APAC Nucleic Acid–Based Diagnostic Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid–Based Diagnostic Market Forecast
10.3.2 Japan Nucleic Acid–Based Diagnostic Market Forecast
10.3.3 Korea Nucleic Acid–Based Diagnostic Market Forecast
10.3.4 Southeast Asia Nucleic Acid–Based Diagnostic Market Forecast
10.3.5 India Nucleic Acid–Based Diagnostic Market Forecast
10.3.6 Australia Nucleic Acid–Based Diagnostic Market Forecast
10.4 Europe Nucleic Acid–Based Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid–Based Diagnostic Market Forecast
10.4.2 France Nucleic Acid–Based Diagnostic Market Forecast
10.4.3 UK Nucleic Acid–Based Diagnostic Market Forecast
10.4.4 Italy Nucleic Acid–Based Diagnostic Market Forecast
10.4.5 Russia Nucleic Acid–Based Diagnostic Market Forecast
10.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid–Based Diagnostic Market Forecast
10.5.2 South Africa Nucleic Acid–Based Diagnostic Market Forecast
10.5.3 Israel Nucleic Acid–Based Diagnostic Market Forecast
10.5.4 Turkey Nucleic Acid–Based Diagnostic Market Forecast
10.5.5 GCC Countries Nucleic Acid–Based Diagnostic Market Forecast
10.6 Global Nucleic Acid–Based Diagnostic Forecast by Type (2024-2029)
10.7 Global Nucleic Acid–Based Diagnostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Nucleic Acid–Based Diagnostic Product Offered
11.4.3 BD Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Nucleic Acid–Based Diagnostic Product Offered
11.6.3 Roche Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Information
11.7.2 Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina, Inc Main Business Overview
11.7.5 Illumina, Inc Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Nucleic Acid–Based Diagnostic Product Offered
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid–Based Diagnostic Market Size 2018-2029
2.1.2 Nucleic Acid–Based Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid–Based Diagnostic Segment by Type
2.2.1 Nucleic Acid Molecular Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Thermostatic Amplification
2.2.4 Gene Sequencing
2.2.5 Biochip Technology
2.3 Nucleic Acid–Based Diagnostic Market Size by Type
2.3.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Nucleic Acid–Based Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Clinical Laboratory
2.4.3 Research Institutions
2.4.4 Clinic
2.4.5 Other
2.5 Nucleic Acid–Based Diagnostic Market Size by Application
2.5.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
3 NUCLEIC ACID–BASED DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nucleic Acid–Based Diagnostic Market Size Market Share by Players
3.1.1 Global Nucleic Acid–Based Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID–BASED DIAGNOSTIC BY REGIONS
4.1 Nucleic Acid–Based Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
5.3 Americas Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
6.3 APAC Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid–Based Diagnostic by Country (2018-2023)
7.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid–Based Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID–BASED DIAGNOSTIC MARKET FORECAST
10.1 Global Nucleic Acid–Based Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid–Based Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid–Based Diagnostic Forecast
10.1.3 APAC Nucleic Acid–Based Diagnostic Forecast
10.1.4 Europe Nucleic Acid–Based Diagnostic Forecast
10.1.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast
10.2 Americas Nucleic Acid–Based Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid–Based Diagnostic Market Forecast
10.2.2 Canada Nucleic Acid–Based Diagnostic Market Forecast
10.2.3 Mexico Nucleic Acid–Based Diagnostic Market Forecast
10.2.4 Brazil Nucleic Acid–Based Diagnostic Market Forecast
10.3 APAC Nucleic Acid–Based Diagnostic Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid–Based Diagnostic Market Forecast
10.3.2 Japan Nucleic Acid–Based Diagnostic Market Forecast
10.3.3 Korea Nucleic Acid–Based Diagnostic Market Forecast
10.3.4 Southeast Asia Nucleic Acid–Based Diagnostic Market Forecast
10.3.5 India Nucleic Acid–Based Diagnostic Market Forecast
10.3.6 Australia Nucleic Acid–Based Diagnostic Market Forecast
10.4 Europe Nucleic Acid–Based Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid–Based Diagnostic Market Forecast
10.4.2 France Nucleic Acid–Based Diagnostic Market Forecast
10.4.3 UK Nucleic Acid–Based Diagnostic Market Forecast
10.4.4 Italy Nucleic Acid–Based Diagnostic Market Forecast
10.4.5 Russia Nucleic Acid–Based Diagnostic Market Forecast
10.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid–Based Diagnostic Market Forecast
10.5.2 South Africa Nucleic Acid–Based Diagnostic Market Forecast
10.5.3 Israel Nucleic Acid–Based Diagnostic Market Forecast
10.5.4 Turkey Nucleic Acid–Based Diagnostic Market Forecast
10.5.5 GCC Countries Nucleic Acid–Based Diagnostic Market Forecast
10.6 Global Nucleic Acid–Based Diagnostic Forecast by Type (2024-2029)
10.7 Global Nucleic Acid–Based Diagnostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Nucleic Acid–Based Diagnostic Product Offered
11.4.3 BD Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Nucleic Acid–Based Diagnostic Product Offered
11.6.3 Roche Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Information
11.7.2 Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina, Inc Main Business Overview
11.7.5 Illumina, Inc Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Nucleic Acid–Based Diagnostic Product Offered
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nucleic Acid Molecular Hybridization
Table 3. Major Players of Polymerase Chain Reaction
Table 4. Major Players of Thermostatic Amplification
Table 5. Major Players of Gene Sequencing
Table 6. Major Players of Biochip Technology
Table 7. Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 10. Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 13. Global Nucleic Acid–Based Diagnostic Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2018-2023)
Table 15. Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
Table 16. Nucleic Acid–Based Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nucleic Acid–Based Diagnostic Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Regions (2018-2023)
Table 21. Global Nucleic Acid–Based Diagnostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2018-2023)
Table 25. Americas Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 27. Americas Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 29. APAC Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Table 31. APAC Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 33. APAC Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 35. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2018-2023)
Table 37. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 39. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Nucleic Acid–Based Diagnostic
Table 48. Key Market Challenges & Risks of Nucleic Acid–Based Diagnostic
Table 49. Key Industry Trends of Nucleic Acid–Based Diagnostic
Table 50. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Agilent Technologies Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 55. Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
Table 56. Agilent Technologies Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Agilent Technologies Main Business
Table 58. Agilent Technologies Latest Developments
Table 59. Danaher Corporation Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 60. Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
Table 61. Danaher Corporation Main Business
Table 62. Danaher Corporation Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Danaher Corporation Latest Developments
Table 64. Abbott Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 65. Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 66. Abbott Laboratories Main Business
Table 67. Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Abbott Laboratories Latest Developments
Table 69. BD Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 70. BD Nucleic Acid–Based Diagnostic Product Offered
Table 71. BD Main Business
Table 72. BD Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. BD Latest Developments
Table 74. Bio-Rad Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 75. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 76. Bio-Rad Laboratories Main Business
Table 77. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Bio-Rad Laboratories Latest Developments
Table 79. Roche Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 80. Roche Nucleic Acid–Based Diagnostic Product Offered
Table 81. Roche Main Business
Table 82. Roche Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Roche Latest Developments
Table 84. Illumina, Inc Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 85. Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
Table 86. Illumina, Inc Main Business
Table 87. Illumina, Inc Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Illumina, Inc Latest Developments
Table 89. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 90. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
Table 91. Thermo Fisher Scientific Inc. Main Business
Table 92. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Thermo Fisher Scientific Inc. Latest Developments
Table 94. Merck KGaA Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 95. Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Merck KGaA Latest Developments
Table 99. Qiagen Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 100. Qiagen Nucleic Acid–Based Diagnostic Product Offered
Table 101. Qiagen Main Business
Table 102. Qiagen Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Qiagen Latest Developments
Table 1. Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nucleic Acid Molecular Hybridization
Table 3. Major Players of Polymerase Chain Reaction
Table 4. Major Players of Thermostatic Amplification
Table 5. Major Players of Gene Sequencing
Table 6. Major Players of Biochip Technology
Table 7. Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 10. Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 13. Global Nucleic Acid–Based Diagnostic Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2018-2023)
Table 15. Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
Table 16. Nucleic Acid–Based Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nucleic Acid–Based Diagnostic Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Regions (2018-2023)
Table 21. Global Nucleic Acid–Based Diagnostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2018-2023)
Table 25. Americas Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 27. Americas Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 29. APAC Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Table 31. APAC Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 33. APAC Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 35. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2018-2023)
Table 37. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 39. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Nucleic Acid–Based Diagnostic
Table 48. Key Market Challenges & Risks of Nucleic Acid–Based Diagnostic
Table 49. Key Industry Trends of Nucleic Acid–Based Diagnostic
Table 50. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Agilent Technologies Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 55. Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
Table 56. Agilent Technologies Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Agilent Technologies Main Business
Table 58. Agilent Technologies Latest Developments
Table 59. Danaher Corporation Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 60. Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
Table 61. Danaher Corporation Main Business
Table 62. Danaher Corporation Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Danaher Corporation Latest Developments
Table 64. Abbott Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 65. Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 66. Abbott Laboratories Main Business
Table 67. Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Abbott Laboratories Latest Developments
Table 69. BD Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 70. BD Nucleic Acid–Based Diagnostic Product Offered
Table 71. BD Main Business
Table 72. BD Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. BD Latest Developments
Table 74. Bio-Rad Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 75. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 76. Bio-Rad Laboratories Main Business
Table 77. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Bio-Rad Laboratories Latest Developments
Table 79. Roche Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 80. Roche Nucleic Acid–Based Diagnostic Product Offered
Table 81. Roche Main Business
Table 82. Roche Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Roche Latest Developments
Table 84. Illumina, Inc Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 85. Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
Table 86. Illumina, Inc Main Business
Table 87. Illumina, Inc Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Illumina, Inc Latest Developments
Table 89. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 90. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
Table 91. Thermo Fisher Scientific Inc. Main Business
Table 92. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Thermo Fisher Scientific Inc. Latest Developments
Table 94. Merck KGaA Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 95. Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Merck KGaA Latest Developments
Table 99. Qiagen Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 100. Qiagen Nucleic Acid–Based Diagnostic Product Offered
Table 101. Qiagen Main Business
Table 102. Qiagen Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Qiagen Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nucleic Acid–Based Diagnostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2022)
Figure 8. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2022
Figure 10. Nucleic Acid–Based Diagnostic in Hospital
Figure 11. Global Nucleic Acid–Based Diagnostic Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Nucleic Acid–Based Diagnostic in Clinical Laboratory
Figure 13. Global Nucleic Acid–Based Diagnostic Market: Clinical Laboratory (2018-2023) & ($ Millions)
Figure 14. Nucleic Acid–Based Diagnostic in Research Institutions
Figure 15. Global Nucleic Acid–Based Diagnostic Market: Research Institutions (2018-2023) & ($ Millions)
Figure 16. Nucleic Acid–Based Diagnostic in Clinic
Figure 17. Global Nucleic Acid–Based Diagnostic Market: Clinic (2018-2023) & ($ Millions)
Figure 18. Nucleic Acid–Based Diagnostic in Other
Figure 19. Global Nucleic Acid–Based Diagnostic Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2022
Figure 21. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player in 2022
Figure 22. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 24. APAC Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 25. Europe Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 27. Americas Nucleic Acid–Based Diagnostic Value Market Share by Country in 2022
Figure 28. United States Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region in 2022
Figure 33. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2022
Figure 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2022
Figure 35. China Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country in 2022
Figure 42. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Figure 43. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Figure 44. Germany Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 58. APAC Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 59. Europe Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 61. United States Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 62. Canada Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 65. China Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 66. Japan Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 67. Korea Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 69. India Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 70. Australia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 71. Germany Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 72. France Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 73. UK Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 74. Italy Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 75. Russia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 76. Spain Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 79. Israel Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 82. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nucleic Acid–Based Diagnostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2022)
Figure 8. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2022
Figure 10. Nucleic Acid–Based Diagnostic in Hospital
Figure 11. Global Nucleic Acid–Based Diagnostic Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Nucleic Acid–Based Diagnostic in Clinical Laboratory
Figure 13. Global Nucleic Acid–Based Diagnostic Market: Clinical Laboratory (2018-2023) & ($ Millions)
Figure 14. Nucleic Acid–Based Diagnostic in Research Institutions
Figure 15. Global Nucleic Acid–Based Diagnostic Market: Research Institutions (2018-2023) & ($ Millions)
Figure 16. Nucleic Acid–Based Diagnostic in Clinic
Figure 17. Global Nucleic Acid–Based Diagnostic Market: Clinic (2018-2023) & ($ Millions)
Figure 18. Nucleic Acid–Based Diagnostic in Other
Figure 19. Global Nucleic Acid–Based Diagnostic Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2022
Figure 21. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player in 2022
Figure 22. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 24. APAC Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 25. Europe Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2018-2023 ($ Millions)
Figure 27. Americas Nucleic Acid–Based Diagnostic Value Market Share by Country in 2022
Figure 28. United States Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region in 2022
Figure 33. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2022
Figure 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2022
Figure 35. China Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country in 2022
Figure 42. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Figure 43. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Figure 44. Germany Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Nucleic Acid–Based Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 58. APAC Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 59. Europe Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 61. United States Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 62. Canada Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 65. China Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 66. Japan Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 67. Korea Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 69. India Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 70. Australia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 71. Germany Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 72. France Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 73. UK Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 74. Italy Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 75. Russia Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 76. Spain Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 79. Israel Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Nucleic Acid–Based Diagnostic Market Size 2024-2029 ($ Millions)
Figure 82. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Application (2024-2029)
